RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
about
Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cellsAnti-tumor effects of Atractylenolide I on bladder cancer cells.Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT.Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR PathwayFailure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells.Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells.ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma.Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells.NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis.Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerMechanism study of isoflavones as an anti-retinoblastoma progression agent.Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
P2860
Q33850034-F48DDD9B-0AC9-4FC8-BFB6-7D4FFF85337EQ35991555-F517D162-EB9D-4F72-B07B-168267BE3649Q36639263-999EFB70-5B1D-483D-A7F7-87CF2B36A904Q36847307-07BB1D79-2818-4755-80BD-48D8A20E9686Q36953023-C111C9EE-DA42-4BB8-AED5-265E5B3C8280Q36983497-886A419E-6E49-4B8C-891D-6D46EE06F18CQ37414261-3CD52725-9B2E-486E-AC8C-3AFD847D6400Q37465944-638DEE59-1E18-48DC-BB84-D99F5BEFCE76Q37631210-E15B8C00-8235-4AC7-8A53-44B9F88AC6FBQ37631384-D2544A88-9CE3-4F6D-9796-F88A2ECCCF30Q38733769-68879C61-D734-4EC4-9B38-ED4AA54952DDQ38739223-E683C920-E02B-4B2A-8489-4E008609A180Q38815411-1546BF6B-4F0E-4EBA-A8EE-31B5B4CB3F99Q41472484-B8194298-53E2-4703-BDAD-F1DD23582058Q42144129-15D54D02-F03A-497E-8C89-608A87C7FC5EQ45928122-65B1477C-D51D-4B85-8085-B67D26C71A26Q47881043-EB201F4A-B1FD-497A-BFA6-60879A137761
P2860
RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@ast
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@en
type
label
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@ast
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@en
prefLabel
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@ast
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
RY-2f, an isoflavone analog, o ...... 3K/AKT/mTOR signaling pathway.
@en
P2093
Bingzhi Liu
Mingming Liu
Qian Zhang
P2860
P304
25281-25294
P356
10.18632/ONCOTARGET.4634
P407
P577
2015-07-30T00:00:00Z